XML 23 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation
9 Months Ended
Oct. 28, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation
For the thirty-nine weeks ended October 28, 2017 and October 29, 2016, stock-based compensation expense was $14.7 million and $15.5 million, respectively. As of October 28, 2017, approximately 9.3 million shares remain available for future grants of equity awards under our Amended and Restated 2012 Omnibus Stock and Incentive Plan, which was amended and restated effective June 22, 2017.
Restricted Stock Awards
Restricted stock award activity for the thirty-nine weeks ended October 28, 2017 was as follows:

Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
2,463,186

 
$
13.87

Granted
1,396,680

 
13.39

Vested
(1,029,675
)
 
14.48

Forfeited
(272,547
)
 
14.53

Unvested, end of period
2,557,644

 
13.29


Performance-based Stock Units
For the thirty-nine weeks ended October 28, 2017, we granted performance-based restricted stock units (“PSUs”), contingent upon the achievement of a Company-specific performance goal during fiscal 2017. Any units earned as a result of the achievement of this goal will be settled in unvested shares of our common stock on the first anniversary of the grant date. Such unvested shares will then vest on the second and third anniversary dates.
Performance-based restricted stock unit activity for the thirty-nine weeks ended October 28, 2017 was as follows:
 
Number of
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested, beginning of period
652,248

 
$
13.28

Granted
601,137

 
13.93

Vested
(279,375
)
 
13.54

Forfeited
(112,046
)
 
13.22

Unvested, end of period
861,964

 
13.66


 
Stock Option Awards
For the thirty-nine weeks ended October 28, 2017 and October 29, 2016, we did not grant any stock options.
Stock option activity for the thirty-nine weeks ended October 28, 2017 was as follows:
 
Number of
Shares
 
Weighted
 Average
Exercise Price
Outstanding, beginning of period
577,246

 
$
13.58

Granted

 

Exercised
(8,000
)
 
10.15

Forfeited or expired
(144,334
)
 
17.21

Outstanding and exercisable at October 28, 2017
424,912

 
12.42